MeSH D004381 - duodenal ulcer
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Clarithromycin | Biaxin | 1991-10-31 | |||
| Famotidine | Famotidine | 2001-12-17 | ||||
| Accord Healthcare | Esomeprazole | Esomeprazole | 2015-09-25 | |||
| Ajanta Pharma | Clarithromycin | Clarithromycin | 2019-04-25 | |||
| Lansoprazole | Lansoprazole | 2016-10-14 | ||||
| Esomeprazole, Naproxen | Naproxen Esomeprazole Magnesium | 2022-10-06 | ||||
| Omeprazole | Omeprazole Bicarbonate | 2016-07-15 | ||||
| Famotidine | Famotidine | 2023-09-18 | ||||
| Akorn | Famotidine | Famotidine | 2014-05-30 | |||
| Alembic Pharmaceuticals | Clarithromycin | Clarithromycin | 2022-01-31 | |||
| Famotidine | Famotidine | 2009-05-22 | ||||
| Alkem Laboratories | Esomeprazole | Esomeprazole Magnesium | 2017-10-20 | |||
| Famotidine, Ibuprofen | Ibuprofen Famotidine | 2021-08-03 | ||||
| Lansoprazole | Lansoprazole | 2019-01-18 | ||||
| Rabeprazole | Rabeprazole | 2018-04-24 | ||||
| Famotidine | Famotidine | 2022-01-07 | ||||
| Allergan | Clarithromycin | Clarithromycin | 2004-06-24 | |||
| Famotidine | Famotidine | 2001-04-16 | ||||
| Esomeprazole, Naproxen | Naproxen Esomeprazole Magnesium | 2022-08-24 | ||||
| Omeprazole | Omeprazole | 2008-05-30 | ||||
| Amneal Pharmaceuticals | Esomeprazole | Esomeprazole Magnesium | 2019-04-10 | |||
| Famotidine | Famotidine | 2022-08-04 | ||||
| Rabeprazole | Rabeprazole | 2015-07-31 |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%8/8
Phase 3
79%23/29
Approved: 14Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use